US · Financial Services

Molecular Pharmacology (USA) Ltd (MLPH)

Shell Companies

Molecular Pharmacology (USA) Ltd (MLPH) is listed on US in the Financial Services sector. Industry: Shell Companies. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MLPH

P/E ratio

18.00

Molecular Pharmacology (USA) Ltd (MLPH) — FAQ

What is MLPH's P/E ratio?

The price-to-earnings (P/E) ratio for Molecular Pharmacology (USA) Ltd (MLPH) is 18.00 (data as of 2026-05-23).

Does Molecular Pharmacology (USA) Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Molecular Pharmacology (USA) Ltd (MLPH). Check the MyAverix Finance app for the latest dividend data.

What sector is Molecular Pharmacology (USA) Ltd in?

Molecular Pharmacology (USA) Ltd (MLPH) is classified in the Financial Services sector (Shell Companies industry).

What exchange is MLPH listed on?

MLPH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

Administradora Americana de Inversiones S.A. (AAISA) Aflac Incorporated (A1FL34) Agricultural Bank Of China (1288) AIA Group Ltd (1299) American International Group, Inc. (AIGB34) Ameriprise Financial Inc. (A1MP34) Arthur J. Gallagher & Co. (A1JG34) Banco Santander S.A. (BSD2)